Cite
HARVARD Citation
Karuturi, M. et al. (n.d.). Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial. Leukemia & lymphoma. 57 (2), pp. 445-447. [Online].